COMP <GO>
CLBT vs VIA // PIOTROSKI F-SCORE QUALITY
Cellebrite DI Ltd. (NASDAQ) VS. Via Transportation Inc. (Class A) (NYSE) • 15-METRIC TALLY: CLBT 7
— VIA 3
▲ PIOTROSKI F-SCORE QUALITY LEADER: CLBT
LAST: $12.28 (+3.02%) • MKT CAP: $3.09B
piotroski-score
8/9
LAST: $36.01 (-1.04%) • MKT CAP: $2.94B
piotroski-score
4/9
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CLBT VS. VIA)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CLBT | VIA | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 84.20% | 39.60% | +44.60 | CLBT | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 14.60% | -23.60% | +38.20 | CLBT | /roic <GO> |
| EV/EBITDA & P/E Valuation | 38.1x | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 5.19% | -1.11% | +6.30 | CLBT | /fcf-yield <GO> |
| Operating Margin | 14.00% | -17.60% | +31.60 | CLBT | /operating-margins <GO> |
| Net Profit Margin | 16.50% | -22.20% | +38.70 | CLBT | /net-margins <GO> |
| Revenue Growth (YoY) | 18.60% | 28.60% | -10.00 | VIA | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 4.95 | 15.30 | -10.35 | VIA | /balance-sheet <GO> |
| Piotroski F-Score Quality ACTIVE | 8/9 | 4/9 | +4.00 | CLBT | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 59.9 | 65.1 | -5.20 | VIA | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 33.1x | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $3.09B | $2.94B | $151.5M | CLBT | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CLBT REV | VIA REV | CLBT GROSS % | VIA GROSS % | CLBT FCF | VIA FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $475.7M | $434.3M | 84.2% | 39.6% | $160.3M | -$32.5M |
| FY 2024 | $401.2M | $337.6M | 84.4% | 38.8% | $123.6M | -$71.0M |
| FY 2023 | $325.1M | $248.9M | — | — | $102.1M | -$92.6M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CLBT // BETA —
VIA // BETA —